Welcome

... to the pages of Key Opinions in Medicine (KOM) KOM is a newsletter service delivered by Wiley-Blackwell to update healthcare professionals on new developments across various therapy areas.

KOM began its life with Dermatology and Hematology, but we are constantly trying to broaden our specturm and grow. We are looking forward to interaction with our readers so please feel free to send questions and comments to us.

Latest Issues

Controversies in the management of actinic keratoses in the 21st century

Debate about the optimal management of actinic keratoses shows no signs of abating. On 21 March 2013, a group of leading dermatologists met to discuss issues affecting clinical practice. This meeting report reflects their views and is accompanied by five short videos.

Topic: Dermatology issue: 6/2013

Behandlungsschema der aktinischen Keratose

Ergebnisse des Onkoderm-Workshops „Praxisorientierte aktinische Keratose-Behandlung in der Fläche“ im Dezember 2012 in Bonn. Onkoderm-Teilnehmer: Prof. Dr. med. Uwe Reinhold, Dr. med. Ralph von Kiedrowski, Dr. med. Hanspeter Prieur, Dr. med. Peter Radny, Dr. med. Lutz Schmitz (in Vertretung von Prof. Dr. med. Thomas

Dirschka)

Topic: Dermatology issue: 5/2013

Choosing field-directed therapy in management of actinic keratosis: the role of topical imiquimod 3.75%

This KOM focuses on the role of imiquimod 3.75% cream, a new field-directed treatment, in the management of actinic keratosis.

Topic: Dermatology issue: 4/2013

Conference KOM - DDG Vorbericht

Vorbericht der DDG-Tagung in Dresden im April 2013.

 

Preview of the German Society for Dermatology (DDG) meeting in Dresden in April 2013.

Topic: Conference issue: 1/2013

The challenge of rapid and targeted treatment of acute bleeding

Addressing the current challenges involved in the treatment of acute and life-threatening bleeding is key for improving patient outcomes. The timing and nature of the haemostatic interventions are currently in focus. Recent military experience has brought massive transfusion protocols into the civilian setting, while improved point-of-care technologies and the wide availability of purified clotting factor concentrates now allow for the implementation of early, targeted, goal-directed therapy. The evidence supporting the use of these approaches was critically appraised by four leading experts at a CSL Behring-sponsored satellite symposium entitled: ‘The challenge of rapid and targeted treatment of acute bleeding’ at the European Society of Anaesthesiology Congress (Euroanaesthesia 2012), and the benefits of a multidisciplinary approach to coagulation management were highlighted.

Topic: Haematology issue: 2/2013

Languages

KOM is an international publication that can appear in different languages. We offer our sponsors the option to publish across multiple languages or choose one. Please let us know when you need an issue in another language than the one shown.